Real Estate
Ultra-HNIs in India Heavily Invest in Commercial Real Estate: Equities and Fine Art Also Gain Traction
A significant 29% of Ultra-High Net Worth Individuals (Ultra-HNIs) in India are investing in commercial real estate, making it the second most popular asset class after equities. However, the investment landscape is diverse, with fine art and other assets also gaining attention.
real estate news
India's Ultra-Rich Diving into Commercial Real Estate: Equities and Fine Art Follow Suit
In a striking shift, nearly half of India's ultra-rich are now investing in commercial real estate, with equities and fine art also gaining popularity. This trend is expected to democratize the asset class, paving the way for greater retail participation and market expansion in Real Estate Investment Trusts (REITs).
Real Estate
Why Young Investors Should Consider Equity Investments
Equities offer young investors a viable and accessible way to build wealth over the long term. Unlike real estate or private equity, which require significant initial capital, equities can be started with small, regular investments through SIPs, making them ideal for young investors.
Real Estate
Top Large-Cap Picks for Emkay Institutional Equities: Zomato, Tata Motors, and Lupin
Emkay Institutional Equities, a subsidiary of Emkay Global Financial Services Limited, is bullish on discretionary, real estate, and healthcare sectors. Here are their top large-cap picks: Zomato, Tata Motors, and Lupin.
Real Estate
Alexandria Real Estate Equities SWOT Analysis: Navigating Life Sciences Real Estate Challenges
Alexandria Real Estate Equities (NYSE:ARE), a prominent real estate investment trust (REIT) with a focus on life sciences properties, is currently facing significant market headwinds. Despite its strong portfolio, the company is grappling with supply chal
real estate news
Alexandria Real Estate Equities: Navigating the Life Sciences Market amid Supply Challenges
Alexandria Real Estate Equities (NYSE: ARE), a prominent real estate investment trust (REIT) focusing on life sciences properties, is facing significant headwinds in the current market. Despite its robust portfolio, the company must address supply issues